QCOR News 88.43 05/16/2014 05:24:34 Questcor Pharmaceuticals

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Questcor Pharmaceuticals (QCOR) 88.43 $QCOR

Shares of QCOR Up 30.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 15, 9:11AM CDT
SmarTrend identified an Uptrend for Questcor Pharmaceuticals (NASDAQ:QCOR) on April 1st, 2014 at $67.41. In approximately 1 month, Questcor Pharmaceuticals has returned 30.01% as of today's recent price of $87.64.

Questcor (QCOR) is Overbought: Is A Drop Coming? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 15, 8:00AM CDT
Questcor (QCOR) is Overbought: Is A Drop Coming?

Questcor Enters Into Development Collaboration Agreement Covering Novel Receptor-Selective Melanocortin Peptides
PR Newswire - Wed May 14, 8:00AM CDT
Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that it has entered into a development collaboration agreement with an undisclosed privately held European company to develop novel melanocortin peptides. The collaboration includes an option to acquire the technology during clinical development. Along with the June 2013 acquisition of Synacthen®, this transaction significantly expands Questcor's portfolio of melanocortin therapeutics and further establishes the company as the leader in this important emerging field of medicine.

Post Earnings Update: Questcor Pharmaceuticals Has Climbed 10.5% Higher in Past 2 Weeks (QCOR)
Comtex SmarTrend(R) - Mon May 12, 11:42AM CDT
When Questcor Pharmaceuticals (NASDAQ:QCOR) reported earnings 14 days ago on April 28th, 2014, analysts, on average, expected the company to report earnings of $1.61 on sales of $240.8 million. Questcor Pharmaceuticals actually reported earnings of $1.51 per share on sales of $227.1 million, missing EPS estimates by $0.10 and missing revenue estimates by $13.6 million. Since the company's report, shares of Questcor Pharmaceuticals have risen from $79.05 to $87.34, representing a gain of 10.5% in the past 14 days.

Mallinckrodt Pharmaceuticals and Questcor Pharmaceuticals Announce Early Termination of HSR Act Waiting Period
Business Wire - Mon May 12, 6:01AM CDT
Mallinckrodt plc (NYSE: MNK), and Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR" , in connection with Mallinckrodt's proposed acquisition of Questcor, was terminated by the United States Federal Trade Commission on May 9, 2014.

Webcast Schedules, Clinical Study Results, Stock Price Movements, and Grants - Analyst Notes on Illumina, Questcor, Quest Diagnostics, Raytheon and Lockheed Martin
PR Newswire - Mon May 12, 6:00AM CDT
Today, Analysts Review released its analysts' notes regarding Illumina Inc. (NASDAQ: ILMN), Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), Quest Diagnostics Inc. (NYSE: DGX), Raytheon Co. (NYSE: RTN) and Lockheed Martin Corporation (NYSE: LMT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2321-100free.

Scanning Equities that Reached New highs -- Research on Energy Transfer Equity, Questcor Pharma, Health Net, and Molson Coors Brewing
PR Newswire - Thu May 08, 12:30PM CDT
The markets on Wednesday, May 07, 2014 ended on a mixed note as the Dow Jones Industrial Average finished the day at 16,518.54, up 0.72%, and the NASDAQ Composite closed at 4,067.67, down 0.32%. The S&P 500 finished the session 0.56% higher at 1,878.21. The gains were broad based as eight out of ten sectors ended the session in positive. Investor-Edge looks at some of the equities that hit a new 52-week high during the last session. These include Energy Transfer Equity L.P. (NYSE: ETE), Questcor Pharmaceuticals Inc. (NASDAQ: QCOR), Health Net Inc. (NYSE: HNT) and Molson Coors Brewing Company (NASDAQ: TAP). Free technical research on ETE, QCOR, HNT and TAP can be downloaded upon signing up at:

Valeant Q1 Mixed, But Strong 2014 Guidance Affirmed
at Investor's Business Daily - Thu May 08, 10:19AM CDT
Canadian drugmaker Valeant Pharmaceuticals International (VRX) reported a mixed but mostly in-line Q1 Thursday, as management continued to press its case for a merger with Allergan (AGN). Valeant's stock rose fractionally on the stock market today....

Mallinckrodt plc Reports Fiscal 2014 Second Quarter Financial Results; Increases Full-Year 2014 Guidance
Business Wire - Thu May 08, 5:01AM CDT
--Increases guidance on full-year revenue and full-year adjusted diluted earnings per share reflecting strength of base business and acquisition of Cadence

After Yesterday's Rally of 2.53% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed May 07, 5:17PM CDT
Questcor Pharmaceuticals (NASDAQ:QCOR) traded in a range yesterday that spanned from a low of $83.51 to a high of $86.51. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $85.00 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Uptrend Call Working As Questcor Pharmaceuticals Stock Rises 28.1% (QCOR)
Comtex SmarTrend(R) - Wed May 07, 4:46PM CDT
SmarTrend identified an Uptrend for Questcor Pharmaceuticals (NASDAQ:QCOR) on April 1st, 2014 at $67.41. In approximately 1 month, Questcor Pharmaceuticals has returned 28.13% as of today's recent price of $86.37.

Akorn Q1 EPS Beats, Raises Full-Year Profit Outlook
at Investor's Business Daily - Tue May 06, 11:11AM CDT
Specialty drugmaker Akorn (AKRX) on Tuesday reported first-quarter EPS above views, but revenue was light. The company also raised its full-year profit outlook. Lake Forest, Ill.-based Akorn said that it earned 16 cents per share in the three months...

Clinical Trial Results Indicate Acthar May Significantly Reduce Disease Activity in Patients with Systemic Lupus Erythematosus
PR Newswire - Mon May 05, 8:00AM CDT
Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that results from the first modern clinical study examining the use of H.P. Acthar® Gel (repository corticotropin injection) in systemic lupus erythematosus (SLE) has been published in the journal LUPUS. This independent investigator-initiated ten patient study was conducted at Fiechtner Research, a rheumatology research center, and evaluated the efficacy of Acthar in reducing SLE disease activity among patients who presented with moderately to severely active disease despite receiving traditional SLE maintenance treatments. Acthar is approved by the Food and Drug Administration (FDA) for 19 indications, including for use during an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus.

Questcor CEO's Daughter Granted Huge Pay Raise
at The Street - Fri May 02, 11:20AM CDT
Her salary jumps to more than $1 million in 2013 from $300,000 in 2012, according to Questcor disclosure.

Awards, Stock Price Updates, Quarterly Earnings Releases, and Clinical Study Results - Analyst Notes on Aetna, Regeneron, Questcor, Medtronic and Lilly
PR Newswire - Thu May 01, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Aetna Inc. (NYSE: AET), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), Questcor Pharmaceuticals Inc. (NASDAQ: QCOR), Medtronic Inc. (NYSE: MDT) and Eli Lilly & Co. (NYSE: LLY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1903-100free.

Questcor Pharmaceuticals Up 20.4% Since SmarTrend Uptrend Call (QCOR)
Comtex SmarTrend(R) - Wed Apr 30, 11:05AM CDT
SmarTrend identified an Uptrend for Questcor Pharmaceuticals (NASDAQ:QCOR) on April 1st, 2014 at $67.41. In approximately 4 weeks, Questcor Pharmaceuticals has returned 20.36% as of today's recent price of $81.14.

INVESTOR ALERT - Questcor Pharmaceuticals, Inc.: The Law Offices of Vincent Wong Investigates the Sale of Questcor Pharmaceuticals, Inc. to Mallinckrodt
Business Wire - Wed Apr 30, 10:55AM CDT
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Questcor Pharmaceuticals Inc. (NasdaqGS: QCOR) ("Questcor" in connection with the sale of the Company to Mallinckrodt.

Small-Cap Growth Stocks: On a Roll With Room to Run
Selena Maranjian, The Motley Fool - Motley Fool - Tue Apr 29, 4:17PM CDT
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some small-cap growth stocks to your portfolio but don't have the time or expertise to hand-pick a few, the Vanguard Russell 2000...

Questcor Misses on Earnings & Revs in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 10:40AM CDT
Questcor Pharmaceuticals reported first quarter 2014 earnings per share of $1.24, up from the year-ago earnings of $0.85 per share but missed the Zacks Consensus Estimate of $1.71.

QUESTCOR (QCOR) SHAREHOLDER ALERT - The Law firm of Andrews & Springer LLC Announces An Investigation of Questcor Pharmaceuticals, Inc.
PR Newswire - Mon Apr 28, 6:30PM CDT
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Questcor Pharmaceuticals, Inc. ("Questcor" or the "Company" (NASDAQ: QCOR) relating to the sale of the Company to Mallinckrodt plc (NYSE: MNK) ("Mallinckrodt" . On April 7, 2014, the two companies announced the signing of a definitive merger agreement pursuant to which Mallinckrodt will acquire Questcor in a merger valued at roughly $5.6 billion. As a result of the merger, shareholders are anticipated to receive $30 in cash and .897 shares of Mallinckrodt for each share of Questcor stock.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Memorial Manor's Five-Star Signal in Long-Term Care

Updated Category News Views 106

Care quality is the only score that matters here A nursing home recognition is not the sort of news anybody should read like a trophy-case press release and then forget by lunch. Families make decisions around long-term care when they are tired, worried, and often dealing with a parent or spouse whose needs have changed fast. In that setting, a facility putting up both a...

Continue Reading
ASUS Brings AI Infrastructure Choices to SC26 Floor

Updated Category News Views 154

Compute buyers are sick of being handed one locked box That is the nerve ASUS is pressing at SC26: enterprises want AI infrastructure that fits the job in front of them, not somebody else's tidy product roadmap. The company is pitching a full-stack “AI Factory” blueprint built across Intel, AMD and NVIDIA hardware, running from rack-scale systems and conventional...

Continue Reading
Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 81

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
AES Clears FERC, Nearing Its December 2 Takeover Close

Updated Category News Views 10

One more regulatory gate just swung open for AES, and this deal is finally staring at the finish line instead of wandering through the usual approval swamp. The Federal Energy Regulatory Commission has issued its final order approving AES's acquisition by a consortium led by Global Infrastructure Partners, part of BlackRock, and EQT Infrastructure VI. The last major...

Continue Reading
Radiate Holdco's Q3 Results: What We Know Now

Updated Category News Views 117

Digging Into Third Quarter Highlights Radiate Holdco, LLC has just thrown its third-quarter financial hat into the ring, stirring up some interest in the world of FLFO secured notes and senior notes. The folks in Princeton, N.J., sure know how to keep things exclusive—this intel is only for those holding their Notes or in the pretty exclusive club of qualified...

Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 97

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
Abacus Global Faces Scrutiny Over Accounting Practices

Updated Category News Views 0

Storm Clouds Gather over Abacus Global Management If it ain't one thing, it's another—at least that's what folks holding the bag with Abacus Global (ABX) are thinking right now. News of a pending investigation has dropped like a lead balloon, and the air is thick with scrutiny over their financial dealings. We're jawing about related-party transactions now under the...

Continue Reading
Labcorp's Brazil Trial Push Has Promise and Plenty to Prove

Updated Category News Views 24

Brazilian clinical-trial kit deliveries may soon spend less time tangled in international shipping. That is the practical heart of Labcorp's newly announced collaboration with Grupo Fleury, and frankly, practical is plenty good in this business. Labcorp plans to begin assembling clinical-trial kits locally in Brazil in early 2027, then add laboratory operations by the end...

Continue Reading
A Faded Sign Is a Quiet Leak in Storefront Demand Today

Updated Category News Views 31

Sunlight does not care what the marketing budget said. A storefront can have a decent product, a clean interior and a capable crew, then lose the first impression before anyone reaches the door because its sign looks tired. That is the plainspoken point behind FASTSIGNS' latest guidance on outdoor sign lifespan. This is not glamorous stuff, but it is operationally...

Continue Reading
Unishippers Climbs 18 Slots on 32.4% Sales Growth Run

Updated Category News Views 50

Thirty new franchise units can move the needle fast Unishippers did not inch its way up the Franchise Times Top 400; it put up a number that deserves a hard look. Sales rose 32.4% in 2025, the company added 30 franchise units, and the result was an 18-place jump to No. 81 on the 2026 ranking. In the shipping category, it was named the sales-growth leader. For a business...

Continue Reading

Top 5 Most Recently Viewed Articles

The Exclusion of XRP from Trump's Crypto Reserve Explained

Updated Category News Views 679

Understanding the Strategic Crypto Reserve Exclusion The cryptocurrency world was recently shaken when President Donald Trump issued an executive order that left notable omissions. Among these was XRP, a digital asset that Ripple and its supporters had hoped to see included in a U.S. sovereign crypto reserve. The Ripple Effects of Trump's Order After investing heavily in...

Continue Reading
UKG Stands Out as a Top Leader in Workforce Management Solutions

Updated Category News Views 168

UKG Secures Top Spot in Workforce Management UKG, a leading provider in HR, payroll, workforce management, and cultural solutions, has recently earned recognition for its exceptional contributions to the workforce management field. The company has been named a Leader in the NelsonHall New World Workforce Management 2024 evaluation, showcasing its strong performance across...

Continue Reading
Zillow Unveils Innovative AI Virtual Staging for Listings

Updated Category News Views 283

Zillow Introduces AI-Powered Virtual Staging In an exciting development for real estate, Zillow has recently launched an innovative feature known as Virtual Staging. This tool harnesses the power of artificial intelligence to enhance how listings are showcased, making the home-buying experience even more engaging for potential buyers. Creating a Visual Experience for Home...

Continue Reading
Balchem Corporation: Innovating Health and Nutrition Solutions

Updated Category News Views 296

Balchem Corporation's Upcoming Conference Presentation Balchem Corporation, a prominent global manufacturer known for its specialty ingredients aimed at health and nutrition markets, is set to make a significant presentation at an upcoming virtual conference. The CJS Securities New Ideas for the New Year Virtual Conference will feature notable company figures, including...

Continue Reading
Projected Growth of Cottonseed Oilseed Processing Market

Updated Category News Views 85

Overview of Cottonseed Oilseed Processing Market Growth The cottonseed oilseed processing market is experiencing significant growth, projected to reach $7.7 billion within a decade, showcasing a compound annual growth rate (CAGR) of 6.8%. The increasing demand for vegetable oils, primarily for their versatility and cost-effectiveness, plays a crucial role in this market's...

Continue Reading